Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SynCo Bio Partners, the Netherlands-based biopharmaceutical GMP contract manufacturing organization, has dispatched first drug product batches from its aseptic filling facility, following the expansion of its Class A zone.
Subscribe to our email newsletter
SynCo’s aseptic filling facility is able to fill and lyophilize a range of biopharmaceuticals which include monoclonal antibodies, nucleic acids, proteins, polysaccharides, aluminium containing vaccines, RNA and live biotherapeutics for clinical and market supply.
SynCo CEO Pierre Warffemius said the expansion of the Class A zone is an addition to SynCo Bio Partners’ already contract manufacturing facility in Amsterdam.